Ashraf Ullah Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashraf Ullah Khan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Salman Khan
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan
2 shared publications - Abdul Aziz
Department of Biochemistry, Dr G D Pol Foundation YMT Dental College and Hospital, Kharghar, Navi Mumbai, India
1 shared publication - Adnan Khan
Institute of Chemical Sciences, University of Peshawar, Peshawar, Pakistan
1 shared publication Aman Ullah
Rehman College of Allied Health Sciences, Peshaar, Peshawar 25000, Pakistan
1 shared publicationAmin Ullah
Department of Allied Health Sciences, Iqra National University (INU), Peshawar 25000, Pakistan
1 shared publication- Amir Zeb
Faculty of Pharmaceutical Sciences Abasyn University Peshawar Pakistan abasyn.edu.pk
1 shared publication
Latest Publications
- 9 September 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1617-1635
Deciphering Puerarin’s Therapeutic Potential Against LPS-Induced Nephrotoxicity: A Computational and Animal Model Study
The current project aimed to determine the protective effect of Puerarin against lipopolysaccharide (LPS)-induced renal injury using animal and computational models. The LPS is the integral component of the outer layer of gram-negative bacteria and is associated with multiple organ damage, including the kidney. The animals were pre-treated with the drugs, and following pre-treatment, the animals were administered LPS intraperitoneally (IP). The LPS administration showed a higher mortality rate, i.e., 45%. The Puerarin-treated groups showed marked protection against the LPS-induced mortality compared to the LPS-treated group. The Puerarin administration showed marked improvement in the body temperature, and the wet-to-dry ratio was reduced significantly as compared to only the LPS-treated group. The in vivo activity was followed by the computational studies using docking, molecular dynamics simulation, and binding free energy calculations. The molecular docking of Puerarin was performed against the 3GQL, TGF-B, STAT, SMAD2, and JAK to assess the binding affinity. Following the molecular docking, the MD simulation was performed for 50 ns, and the results showed dynamic stability of the complexes. After the MD simulation, the binding free energy was calculated to validate the results of the molecular docking and MD simulation. In conclusion, Puerarin showed significant activity against LPS-induced renal injury using both in vivoand computational studies; however, further studies will be required to employ Puerarin for the clinical treatment of renal injury.
- 9 September 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 1617-1635
Deciphering Puerarin’s Therapeutic Potential Against LPS-Induced Nephrotoxicity: A Computational and Animal Model Study
The current project aimed to determine the protective effect of Puerarin against lipopolysaccharide (LPS)-induced renal injury using animal and computational models. The LPS is the integral component of the outer layer of gram-negative bacteria and is associated with multiple organ damage, including the kidney. The animals were pre-treated with the drugs, and following pre-treatment, the animals were administered LPS intraperitoneally (IP). The LPS administration showed a higher mortality rate, i.e., 45%. The Puerarin-treated groups showed marked protection against the LPS-induced mortality compared to the LPS-treated group. The Puerarin administration showed marked improvement in the body temperature, and the wet-to-dry ratio was reduced significantly as compared to only the LPS-treated group. The in vivo activity was followed by the computational studies using docking, molecular dynamics simulation, and binding free energy calculations. The molecular docking of Puerarin was performed against the 3GQL, TGF-B, STAT, SMAD2, and JAK to assess the binding affinity. Following the molecular docking, the MD simulation was performed for 50 ns, and the results showed dynamic stability of the complexes. After the MD simulation, the binding free energy was calculated to validate the results of the molecular docking and MD simulation. In conclusion, Puerarin showed significant activity against LPS-induced renal injury using both in vivoand computational studies; however, further studies will be required to employ Puerarin for the clinical treatment of renal injury.
- Open Access
- 13 January 2025
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 19 (1) , 71-90
Integrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
Introduction: Diabetes mellitus (DM), particularly type 2 DM (T2DM), is a chronic metabolic disorder requiringnovel therapeutic approaches as the available therapies are not meeting the current challenges. This study investigatesthe anti-diabetic potential of Vigna unguiculata using a network pharmacology approach, supported byin vitro and in silico analyses.Methods: The plant was collected from Khyber Pakhtunkhwa, Pakistan, and subjected to hydroalcoholic extractionand fractionation. In vitro assays included α-amylase, α-glucosidase, and aldose reductase. Target predictionusing STITCH and SwissTargetPrediction identified 88 common genes linked to T2DM. Protein-protein interaction(PPI) network analysis highlighted key genes like EGFR, PTGS2, and TLR4 as central nodes in diabetes-relatedpathways. Molecular docking was used to study the binding affinities of compounds.Results: IC50 values were determined using IBM SPSS Statistics 21 software. The data underwent analysis usingone-way ANOVA followed by Dunnett’s multiple comparison test. Significance value was determined at *p < 0.05,**p < 0.01 and ***p < 0.001. In-vitro assays demonstrated significant α-amylase, α-glucosidase, and aldose reductaseinhibitory activities. Phytochemical screening identified several bioactive compounds. Functional annotationand KEGG pathway analysis confirmed these genes’ roles in crucial metabolic pathways. Virtual screeningrevealed strong binding affinities of compounds like Stigmasterol, Luteoline, and Quercetin with GSK3B, PTGS2,and TLR4. The Molecular Dynamics (MD) simulation, binding free energy calculations (MM-PBSA and MM-GBSA),confirmed the results of Virtual screening.Conclusion: In short, these findings underscore V. unguiculata as a promising source for anti-diabetic agents, supportingfurther clinical trials for T2DM management.
- 13 January 2025
- Published by Aboutscience Srl in Drug Target Insights
- Vol. 19 (1) , 71-90
Open AccessIntegrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
Introduction: Diabetes mellitus (DM), particularly type 2 DM (T2DM), is a chronic metabolic disorder requiringnovel therapeutic approaches as the available therapies are not meeting the current challenges. This study investigatesthe anti-diabetic potential of Vigna unguiculata using a network pharmacology approach, supported byin vitro and in silico analyses.Methods: The plant was collected from Khyber Pakhtunkhwa, Pakistan, and subjected to hydroalcoholic extractionand fractionation. In vitro assays included α-amylase, α-glucosidase, and aldose reductase. Target predictionusing STITCH and SwissTargetPrediction identified 88 common genes linked to T2DM. Protein-protein interaction(PPI) network analysis highlighted key genes like EGFR, PTGS2, and TLR4 as central nodes in diabetes-relatedpathways. Molecular docking was used to study the binding affinities of compounds.Results: IC50 values were determined using IBM SPSS Statistics 21 software. The data underwent analysis usingone-way ANOVA followed by Dunnett’s multiple comparison test. Significance value was determined at *p < 0.05,**p < 0.01 and ***p < 0.001. In-vitro assays demonstrated significant α-amylase, α-glucosidase, and aldose reductaseinhibitory activities. Phytochemical screening identified several bioactive compounds. Functional annotationand KEGG pathway analysis confirmed these genes’ roles in crucial metabolic pathways. Virtual screeningrevealed strong binding affinities of compounds like Stigmasterol, Luteoline, and Quercetin with GSK3B, PTGS2,and TLR4. The Molecular Dynamics (MD) simulation, binding free energy calculations (MM-PBSA and MM-GBSA),confirmed the results of Virtual screening.Conclusion: In short, these findings underscore V. unguiculata as a promising source for anti-diabetic agents, supportingfurther clinical trials for T2DM management.
- Open Access
- 13 November 2024
- Published by Qeios Ltd
Review of: "Investigation and Synthesis of Benzothiazole-Derived Schiff Base Ligand Against Mycobacterium tuberculosis"
The manuscript is well-structured, and the results are original. Based on my assessment, I recommend major revision of the study. * The authors have only discussed a single compound; it is suggested that the authors provide other compounds of the s...
- 13 November 2024
- Published by Qeios Ltd
Open AccessReview of: "Investigation and Synthesis of Benzothiazole-Derived Schiff Base Ligand Against Mycobacterium tuberculosis"
The manuscript is well-structured, and the results are original. Based on my assessment, I recommend major revision of the study. * The authors have only discussed a single compound; it is suggested that the authors provide other compounds of the s...
- Retracted
- 19 July 2022
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 395 (10) , 1167-1188
RETRACTED ARTICLE: Ameliorative effect of two structurally divergent hydrazide derivatives against DSS-induced colitis by targeting Nrf2 and NF-κB signaling in mice
The environmental factors and genetic vulnerability trigger the inflammatory bowel diseases (IBDs) such as ulcerative colitis and Crohn’s disease. Furthermore, the oxidative stress and inflammatory cytokines have been implicated in the aggravation of the IBDs. The aim of the present study was to investigate the effect of N-(benzylidene)-2-((2-hydroxynaphthalen-1-yl)diazenyl)benzohydrazides (NCHDH and NTHDH) compounds against the DSS-induced colitis in mice. The colitis was induced by 5% dextran sulfate sodium (DSS) dissolved in normal saline for 5 days. The effect of the NCHDH and NTHDH on the behavioral, biochemical, histological, and immunohistological parameters was assessed. The NCHDH and NTHDH treatment improved the behavioral parameters such as food intake, disease activity index, and diarrhea score significantly compared to DSS control. The NCHDH and NTHDH treatments significantly increased the antioxidant enzymes, whereas oxidative stress markers were markedly reduced. Similarly, the NCHDH and NTHDH treatments significantly suppressed the activity of nitric oxide (NO), myeloperoxidase (MPO), and eosinophil peroxidase (EPO). The histological studies showed a significant reduction in inflammation, immune cell infiltration, and fibrosis in the NCHDH- and NTHDH-treated groups. The immunohistochemical results demonstrated that NCHDH and NTHDH treatments markedly increase the expression level of Nrf2, HO-1 (hemeoxygenase-1), TRX (thioredoxin reductase), and IκB compared to the DSS-induced group. In the same way, the NCHDH and NTHDH significantly reduced the NF-κB and COX-2 (cyclooxygenase-2) expression levels. The NCHDH and NTHDH treatment significantly improved the symptoms associated with colitis via inducing antioxidants and attenuating oxidative stress markers.
- 19 July 2022
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 395 (10) , 1167-1188
RetractedRETRACTED ARTICLE: Ameliorative effect of two structurally divergent hydrazide derivatives against DSS-induced colitis by targeting Nrf2 and NF-κB signaling in mice
The environmental factors and genetic vulnerability trigger the inflammatory bowel diseases (IBDs) such as ulcerative colitis and Crohn’s disease. Furthermore, the oxidative stress and inflammatory cytokines have been implicated in the aggravation of the IBDs. The aim of the present study was to investigate the effect of N-(benzylidene)-2-((2-hydroxynaphthalen-1-yl)diazenyl)benzohydrazides (NCHDH and NTHDH) compounds against the DSS-induced colitis in mice. The colitis was induced by 5% dextran sulfate sodium (DSS) dissolved in normal saline for 5 days. The effect of the NCHDH and NTHDH on the behavioral, biochemical, histological, and immunohistological parameters was assessed. The NCHDH and NTHDH treatment improved the behavioral parameters such as food intake, disease activity index, and diarrhea score significantly compared to DSS control. The NCHDH and NTHDH treatments significantly increased the antioxidant enzymes, whereas oxidative stress markers were markedly reduced. Similarly, the NCHDH and NTHDH treatments significantly suppressed the activity of nitric oxide (NO), myeloperoxidase (MPO), and eosinophil peroxidase (EPO). The histological studies showed a significant reduction in inflammation, immune cell infiltration, and fibrosis in the NCHDH- and NTHDH-treated groups. The immunohistochemical results demonstrated that NCHDH and NTHDH treatments markedly increase the expression level of Nrf2, HO-1 (hemeoxygenase-1), TRX (thioredoxin reductase), and IκB compared to the DSS-induced group. In the same way, the NCHDH and NTHDH significantly reduced the NF-κB and COX-2 (cyclooxygenase-2) expression levels. The NCHDH and NTHDH treatment significantly improved the symptoms associated with colitis via inducing antioxidants and attenuating oxidative stress markers.